Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Core EBITDA Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 80.69186.95-48.932.87-25.41

What is the latest Core EBITDA Growth ratio of NATCO PHARMA ?

The latest Core EBITDA Growth ratio of NATCO PHARMA is 80.69 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202480.69
Mar2023186.95
Mar2022-48.93
Mar20212.87
Mar2020-25.41

How is Core EBITDA Growth of NATCO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 80.69
-56.84
Mar2023 186.95
Positive
Mar2022 -48.93
Negative
Mar2021 2.87
Positive
Mar2020 -25.41 -

Other Financial Ratios of NATCO PHARMA


Compare Core EBITDA Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,499.0 Cr -5.5% 1.5% -21.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.5%

1.5%

-21.2%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses